NCT07748195
DNA Methylation in PMR
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Eligibility criteria expanded, about 5 words
- Study sites: 0 to 1
- Notable Start date: Jul 20, 2026 to Aug 31, 2026v3
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Understanding what the exact triggers for immune activation, the specific antigens involved, and the mechanisms underlying disease relapses and glucocorticoid resistance
Timeframe: 12 months
Arms and interventions
PMR diagnosed
individuals who have a PMR diagnosis
Healthy Volunteers
Healthy individuals, without a PMR diagnosis, which will allow age and sex matches with the PMR diagnosed cohort.
Sites
1 site in 1 country
- Dartmouth Hitchcock Medical CenterLebanon, New Hampshire, United States